Discover how spatial biology is reshaping our understanding of the gastrointestinal tract, from cellular diversity to disease mechanisms and treatment insights.
The gastrointestinal (GI) tract is a complex and dynamic organ system essential for digestion, nutrient absorption, and immune surveillance. Recent advancements in spatial biology have provided unprecedented insights into the cellular composition, organization, and regulatory mechanisms within the GI tract. This webinar will explore the latest research findings that highlight the intricate cellular landscapes and their implications for health and disease.
Key Topics Include:
- Cellular Diversity and Regional Differences: Understanding the distinct cell compositions and their functional implications across various regions of the intestine, as revealed by multiplexed imaging and single-nucleus RNA assays.
- Disease Progression in Barrett’s Esophagus: Insights into the multi-omics profiling of esophageal adenocarcinoma progression, emphasizing the coordinated changes in epithelial and stromal cells, extracellular matrix, and tissue mechanics.
- Macrophage Niches in GI Tumors: Discovering the spatially resolved macrophage niches within malignant and benign colon tissues, and their roles in tumor microenvironments and treatment responses.
This webinar will provide a comprehensive view of how spatial biology is transforming our understanding of GI tract health, disease, and treatment approaches, particularly in the realms of cancer progression and immune modulation
Click to watch the webinar recording. To view the presentation full screen simply click the square icon located in the bottom-right corner of the video-viewer.
Presenters
Assistant Professor of Biomedical Engineering
Duke University
John Hickey's Lab sits at the interface of engineering and immunology, using and developing systems immunology tools to investigate tissue structure in situ. They also use multiplexed imaging and computational techniques to characterize spatial cellular responses related to the effectiveness of anti-cancer cell or biomaterial therapies. John has received a number of awards for his work, including the NSF Graduate Research Fellowship, ARCS Scholar, Siebel Scholar, NCI Postdoctoral Fellowship, and American Cancer Society Postdoctoral Fellowship.
Production Partner
Akoya Biosciences
As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode™ Panels and PhenoCycler® Fusion, PhenoImager® Fusion, and PhenoImager HT Instruments.
Additional Content From Akoya Biosciences
Unraveling Immunotherapy Resistance in Advanced Melanoma: Novel Insights from Longitudinal Spatial Multiomics Studies
Explore immunotherapy resistance in melanoma with Dr. Camelia Quek through advanced spatial multiomics and single-cell analysis insights.
Reprogramming the Brain Tumor Microenvironment to Enhance Anti-Tumor Immunity
Join us to learn how recent discoveries about the brain tumor microenvironment can drive new therapeutic strategies to overcome tumor immunosuppression.
A Ready-to-Analyze High-Plex Spatial Signature Development Workflow for Cancer Immunotherapy
In this webinar, Aditya Pratapa and Lorcan Sherry present a new workflow for analyzing multiplex immunoflurescence images.
Additional Content From Scientist.com
How to Avoid Expensive Redesign Cycles in Antibody Discovery
Learn how integrated antibody discovery and engineering strategies can accelerate the path from hit to optimized lead in less than 12 months while minimizing costly redesign cycles.
Beyond Exposure: Integrating PK/PD for Translational Predictive Power
Learn to integrate PK/PD modeling and strategic biomarkers to bridge the translational gap. Improve clinical predictability for NCEs, ADCs, and large molecules in this technical webinar.
Advancing the Manufacture of Mesenchymal Stromal Cells and Derived Extracellular Vesicles in Stirred-Tank Bioreactors Through Enhanced Bioprocess Control
Learn how to scale the production of MSCs and extracellular vesicles using bioreactor control and real-time monitoring for more consistent therapies.
Related Content
Advancing ADC Development: Leveraging AI and Translational Preclinical Models to Improve Clinical Predictability
Join our webinar to discover how to de-risk ADC development through the integration of AI-driven analytics, mouse clinical trials and specialized translational models.
From Biopsy to Better Decisions: Patient-Derived Organoids Predict Treatment Response in Metastatic Colorectal Cancer
Learn how patient-derived organoids predict treatment response in metastatic colorectal cancer and explore findings from the OPTIC study on drug sensitivity and clinical outcomes.
De-Risking Immunotherapy Targets with Next-Gen HLA Discovery Platforms
In this webinar, Rico Buchli, PhD, shares how next-generation soluble HLA peptide discovery platforms can strengthen early immunotherapy R&D - from target identification and confirmation to receptor/drug validation and translational decision-making.